Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pfizer
Pfizer
Page 8 of 37
Health
FDA clears Pfizer boosters for 12-to-15 year-olds
By
Lauran Neergaard
and
The Associated Press
January 3, 2022
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By
Jeremy Kahn
December 29, 2021
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By
David Meyer
December 27, 2021
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By
Matthew Perrone
and
The Associated Press
December 23, 2021
Health
Pfizer pill becomes first FDA-approved home COVID treatment
By
Matthew Perrone
and
The Associated Press
December 22, 2021
Health
Israel to give fourth COVID vaccine doses to combat Omicron, despite lack of data on second boosters
By
David Meyer
December 22, 2021
Health
FDA set to authorize Pfizer and Merck COVID pills this week
By
Josh Wingrove
,
Jennifer Jacobs
,
Robert Langreth
and
Bloomberg
December 21, 2021
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By
Christiaan Hetzner
December 20, 2021
Health
Europe taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
By
Christiaan Hetzner
December 17, 2021
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By
Bloomberg
December 17, 2021
Newsletters
Stocks and crypto falter, looking set to close out the week on a losing streak
By
Bernhard Warner
December 17, 2021
Health
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By
Lauran Neergaard
,
Mike Stobbe
and
The Associated Press
December 16, 2021
Health
As COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
By
Erika Fry
and
Nicolas Rapp
December 15, 2021
Health
Germany’s new health minister delivers a bombshell: The country doesn’t have enough COVID-19 vaccines
By
Christiaan Hetzner
December 15, 2021
Health
Pfizer pill reduces risk of COVID hospitalization and death by 89%, and should protect against Omicron
By
Kylie Logan
December 14, 2021
Most Popular
Personal Finance
Trump turns government into giant debt collector with threat to garnish wages on millions of Americans in default on...
By
Annie Ma
and
The Associated Press
Real Estate
Mark Zuckerberg gifted noise-canceling headphones to his Palo Alto neighbors because of the nonstop construction around...
By
Dave Smith
Retail
Trump just declared Christmas Eve a national holiday. Here’s what’s open and closed
By
Dave Smith